The Safety of Pharmacopuncture on Musculoskeletal Patients

NCT05318859 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2025-09-04

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety of pharmacopuncture by observing any adverse events that may occur after pharmacopuncture treatment in with spinal joint disease hospitalized patients at 7 Korean medicine hospitals and analyzing blood test results.

Conditions

  • Musculoskeletal Diseases or Conditions
  • Spine; Arthrosis

Interventions

OTHER

Pharmacopuncture

Registry (observational study)

Sponsors & Collaborators

  • Jaseng Medical Foundation

    lead OTHER

Principal Investigators

  • In-Hyuk Ha, Ph.D. · Jaseng Medical Foundation

Eligibility

Min Age
19 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-27
Primary Completion
2025-02-03
Completion
2025-02-03

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05318859 on ClinicalTrials.gov